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Trimethoprim/sulfamethoxazole (TMP/SMX) resist-
ance remains a serious threat in the treatment of
Stenotrophomonas maltophilia infections. We analyzed an
international collection of 55 S. maltophilia TMP/SMX-sen-
sitive (S) (n = 30) and -resistant (R) (n = 25) strains for inte-
grons;  sul1,  sul2 and dhfr genes; and insertion element
common region (ISCR) elements. sul1, as part of a class 1
integron, was detected in 17 of 25 TMP/SMX-R. Nine
TMP/SMX-R strains carried sul2; 7 were on large plasmids.
Five TMP/SMX-R isolates were positive for ISCR2, and 4
were linked to sul2; 2 others possessed ISCR3. Two
ISCR2s were adjacent to floR. Six TMP/SMX-S isolates
harbored novel ISCR elements, ISCR9 and ISCR10.
Linkage of ISCR3, ISCR9, and ISCR10 to sul2 and dhfr
genes was not demonstrated. The data from this study indi-
cate that class 1 integrons and ISCR elements linked to
sul2 genes can mediate TMP/SMX resistance in S. mal-
tophilia and are geographically widespread, findings that
reinforce the need for ongoing resistance surveillance.
N
osocomial Stenotrophomonas maltophilia are intrinsi-
cally resistant to a plethora of antimicrobial agents
that severely limit commonly used empiric standard
antimicrobial therapies. S. maltophilia is resistant to many
β-lactams,  β-lactamase inhibitors, and aminoglycosides
(1,2). A recent survey of SENTRY (www.jmilabs.com)
Antimicrobial Surveillance Program isolates indicated that
the newer fluoroquinolones demonstrated good efficacy;
the most active were levofloxacin (6.5% resistance) and
gatifloxacin (14.1%) (3). Furthermore, the resistance to the
polymyxins (20%–32%) is higher than observed in
Pseudomonas aeruginosa (3,4). Because of low resistance
levels (≈5%), trimethoprim/sulfamethoxazole (TMP/
SMX) remains the therapy of choice worldwide. A recent
study encompassing data from Europe, Latin America, and
North America indicates that the level of resistance to
TMP/SMX is 3.8%; however, previous studies indicate
that the level is higher in Latin America than North
America (5,6). Although surveillance studies are few,
resistance to TMP/SMX appears to be emerging, and
recent in vitro modeling studies have shown that combina-
tion therapies of TMP/SMX plus ciprofloxacin and
TMP/SMX plus tobramycin exhibit a greater killing
capacity then TMP/SMX alone (7,8).
S. maltophilia exhibits an array of mechanisms that
singularly or collectively contribute to its multidrug resist-
ance status. Intrinsic resistance includes inducible efflux
pumps (2) and multiple β-lactamase expression (1) but not
mutations in the quinolone resistance–determining region
(9). In addition, S. maltophilia can acquire resistance
through integrons, transposons, and plasmids (10).
Recently, class 1 integrons have been characterized from S.
maltophilia strains isolated in Argentina and Taiwan,
which indicates that they contribute to TMP/SMX resist-
ance through the sul1 gene carried as part of the 3′ end of
the class 1 integron (10).
In addition to class 1 integrons, other mobile elements
are associated with sul genes. For example, Vibrio cholerae
serogroup 0139 is resistant to several antimicrobial agents,
including SMX, and it has been recently shown that the sul2
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named SXT. The resistance genes harbored by SXT are
embedded in a composite transposon-like structure and
were probably acquired recently (11). Within this antimi-
crobial drug resistance region, an insertion element com-
mon region (ISCR) sequence, ISCR2, is adjacent to a sul2
gene that moves by 1-ended transposition. Thus, the possi-
bility exists that sul2 genes can transfer intra- and inter-
generically, including into S. maltophilia. Herein, we
describe the molecular characterization of an international
collection of S. maltophilia isolates and determine their
mechanism of resistance to TMP/SMX, including the first
report of sul2 genes and the first description of insertion




During 1998–2003, a total of 1,744 S. maltophilia iso-
lates collected worldwide were forwarded to the SENTRY
Program (Europe, USA, and Australia) and tested for
antimicrobial drug susceptibility. A TMP/SMX resistance
phenotype was demonstrated for 71. From these isolates,
25 nonclonal strains from patients in North America, Latin
America, and Europe were analyzed by using molecular
methods together with 30 representative isolates that were
TMP/SMX-susceptible. Isolates were identified by using
the Vitek System and confirmed by using API20NE
(bioMérieux, Hazelwood, MO, USA).
Susceptibility Methods
Isolates were tested for susceptibility to TMP/SMX
according to procedures of the Clinical and Laboratory
Standards Institute (CLSI, formerly the National
Committee for Clinical Laboratory Standards [NCCLS])
(12,13) by using broth microdilution methods (TREK
Diagnostics, Cleveland, OH, USA). MIC results were con-
firmed with TMP/SMX. Etests were performed according
to the manufacturer’s directions (AB Biodisk, Solna,
Sweden).
Molecular Materials
PCR primers were purchased from Sigma-Genosys
Ltd. (Pampisford, UK) and are listed in the Table. General
reagents for DNA manipulation were obtained from
Invitrogen (Groningen, the Netherlands). All other
reagents were obtained from Sigma Chemical Co. or BDH
(both of Poole, England, UK).
Strain Typing
Clonality among the S. maltophilia isolates was
assessed by pulsed-field gel electrophoresis (PFGE) fol-
lowed by XbaI digestion of genomic DNA. This assess-
ment was conducted according to the standard 1-day pro-
tocol (16).
Plasmid Isolation
Bacterial plasmids were isolated by the alkaline lysis
method described by Grinsted and Bennett (17).
Essentially, an overnight 10-mL culture was centrifuged
(12,000× g) and suspended in water (250 µL) before 200
µLof lysis solution (0.2 mol/LNaOH, 1% sodium dodecyl
sulfate [SDS]) was added. After lysis, 125 µL of neutraliz-
ing solution (0.3 mol/L potassium acetate, 1 mmol/L
EDTA) was added. After precipitation, the suspension was
centrifuged (12,000× g) and washed twice with 500 µLo f
a 50/50 (v/v) phenol/chloroform solution. The DNA was
precipitated from the solution with the addition of 0.7 vol-
umes of iso-amyl alcohol. The DNA/RNA pellet was
washed twice in 1 mL70% ethanol before being dried. The
DNA was dissolved in 30 µL with 0.1 U RNase.
Southern Hybridization
ISCR and sul2 PCR amplicons generated with primers
CRF/CRFF-r were labeled with P32-CTP by random
primer extension by using a commercially available kit
(Stratagene, Amsterdam, the Netherlands) according to the
manufacturer’s instructions. Unincorporated nucleotides
were removed by passing the labeled DNA through a
Sephadex column (Nick column, Pharmacia Bio-tech,
Uppsala, Sweden).
Agarose gels used for Southern transfer were dena-
tured for 45 min in denaturing solution (0.5 mol/L NaOH,
1.5 mol/L NaCl) before being neutralized in 0.5 mol/L
Tris-HCl, pH 7.5, 1.5 mol/L NaCl for 30 min. DNA was
then transferred to Hybond (Amersham, Buckinghamshire,
UK) nylon membrane by vacuum by using a custom-made
Southern blotting apparatus. The nylon filter was prehy-
bridized for at least 2 h with a blocking solution (6× SSC
[1× SSC is 0.15 mol/L NaCl plus 0.014 mol/L sodium cit-
rate], 0.1% [w/v] polyvinylpyrrolidone 400, 0.1% Ficoll
[v/v], 0.1% bovine serum albumin, 0.5% SDS, 150 µg/mL
denatured calf thymus DNA) at 65°C. The labeled dena-
tured probe was then added to the solution and incubated
overnight at 65°C. Finally, the filter was washed (300 mL
2× SSC, 0.1% [w/v] SDS followed by 0.1× SSC 0.1%
SDS) at 65°C. Autoradiographic images were recorded on
Hyperfilm-MP (Pharmacia Bio-tech), which was exposed
overnight with intensifying screens.
PCR Analysis
The presence of class 1 integrons in each strain was
assessed by using class 1 specific primers. Gene cassettes
embedded within the class 1 integrons were determined by
using primers listed in the Table. Isolates were also
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sul2-F and -R, and sul3-F and -R, respectively. Seven pos-
itive class 1 integron PCR products were chosen random-
ly, extracted from agarose gels after size separation, and
sequenced with IntF, IntR, and custom-made oligonu-
cleotide primers (Table).
The presence of ISCR elements in each strain was also
determined by using primers CRF/CRFF-r designed to
amplify the same 700-bp fragment internal to the open
reading frames (ORFS) of ISCR1–5 (Table). Full-length
ISCR2 elements were amplified with primers designed to
target the ends of ISCR2. Primers used to amplify genes
often associated with ISCR2 or ISCR3 are also given
(Table). Because dhfr genes are associated with ISCR ele-
ments, we also performed molecular analysis of them.
PCRs were conducted in a final volume of 20 µLb y
using 10 µL ABgene Expand Hi-fidelity Master Mix
(ABgene House, Surrey, UK). Primers were used at final
concentrations of 10 µmol/L, and 1 µL of an overnight
bacterial culture (optical density 1.0 at 600 nm) was added
as source of DNA template. The cycling parameters were
as follows: 95°C for 5 min, followed by 30 cycles of 95°C
for 1 min, 55°C for 1 min, and 68°C for 1–4 min, depend-
ing on the sequence to be amplified, and ending with a 5-
min incubation at 68°C.
DNA Sequencing and Analysis
Sequencing was conducted on both strands by the
dideoxyl-chain termination method with a Perkin-Elmer
Biosystems 377 DNA sequencer (Perkin-Elmer, Waltham,
MA, USA). Sequence analysis was performed with the
Lasergene DNASTAR software package (SelectScience
Ltd., Bath, UK). Sequence alignments were conducted
with the ClustalW program (www.ebi.ac.uk/clustalw) and
the PAM 250 matrix.
The sequence of ISCR2, together with the adjacent
sul2 region and the novel ISCR9 and ISCR10, has been
deposited in GenBank. The genetic locus ISCR2-
glmM/sul2 from isolates 5232, 4647, 3800, and 2107 has
been attributed the accession nos. AM182031, 182030,
182029, and 181666, respectively. ISCR9 and ISCR10
have been given the numbers AM182033 and AM182032,
respectively.
Stenotrophomonas maltophilia
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TMP/SMX MICs
TMP/SMX MICs separated the isolates into an obvi-
ous bimodal distribution. The TMP/SMX-resistant isolates
possessed MICs >32 mg/L, whereas the sensitive controls
used as molecular comparators possessed TMP/SMX
MICs ranging from 0.5 to 2 mg/L(Online Appendix Table,
available from http://www.cdc.gov/EID/content/13/4/
559-appT.htm).
Detection and Determination of Class 1 Integrons
Of the 25 TMP/SMX-resistant S. maltophilia isolates
that we analyzed, 17 possessed the sul1 gene as part of the
3′ end of a class 1 integron. None of the TMP/SMX-sus-
ceptible S. maltophilia isolates yielded positive sul1 PCR
products. PFGE analysis (data not shown) showed that
only 2 isolates (9189 and 12221 from Chile) are clonally
related (online Appendix Table). To our knowledge, this is
the first report of sul1-positive S. maltophilia isolates from
North America and Europe. The sul1-positive isolates are
widespread, being from Europe, North America, and South
America. Most (5) were isolated from Brazil. The inte-
grons associated with the sul1 gene vary in size; however,
when 2 strains were isolated from the same country (e.g.,
3438 and 3444, 9189 and 12221, and 98 and 14469), they
possessed integrons of the same size, despite not being
clonally related (Online Appendix Table). Seven of these
integrons were randomly selected to examine their gene
cassettes. The genetic context of the class 1 integrons and
procured gene cassettes are shown in Figure 1. Strains
1893 (Germany) and 9431 (Brazil) possessed only the int
and sul/qac genes. The class 1 integrons from strains 4891
(USA), 9189 (Chile), and 12221 (Chile) contained an
embedded  aacA4 gene cassette. The 2 Mexican strains
(3438 and 3444) contained 2 aminoglycoside-modifying
genes (aacA7 and aadA5) and an unknown ORF (Figure 1)
yet were clonally unrelated, as judged by PFGE profiling.
None of the integrons were the same as those characterized
from strains isolated from Argentina (10).
Detection and Location of sul2 Genes
All 55 isolates (both TMP/SMX resistant and sensi-
tive) were screened for sul2 genes with the primers listed
in the Online Appendix Table. Nine of the isolates gave
PCR products for sul2. None of the TMP/SMX-susceptible
S. maltophilia isolates displayed positive sul2 PCR prod-
ucts. Sequence analysis showed 100% identity with previ-
ous sul2 sequences.
Given that sul2 is normally located on medium-to-
large sized plasmids, plasmids were isolated and character-
ized for sul2 carriage. Plasmid DNA was prepared from
each isolate and used as a template for PCRs by using the
sul2 primer detection set. In every case, a product of the
size expected of sul2 sequence amplification was obtained.
The purity of each plasmid preparation was evaluated by
attempted PCR amplification of the host cell chromosomal
gyrA gene. In no case was an amplification product
obtained when plasmid DNAwas used as template; in con-
trast, a gyrA amplification product of the correct size was
obtained from genomic DNA. These data were later con-
firmed by Southern hybridization that used the labeled sul2
gene as a probe (data not shown). Unsurprisingly, in most
cases sul2 was found on a large plasmid of ≈120 kb; how-
ever, in 2 of 9 sul2-positive isolates, sul2 gene was chro-
mosomally encoded. 
Detection of ISCR Elements in TMP/SMX-sensitive and
-resistant Strains
The sul2 gene and dhfr genes are often found on plas-
mids and in close association with class 1 integrons or
ISCR mobile genetic elements (10,15,18,19). Accordingly,
we investigated the 55 S. maltophilia isolates for ISCR ele-
ments. Seven of the 25 TMP/SMX-resistant isolates yield-
ed PCR products of the expected size (≈700 bp) when the
ISCR specific primers CRF/CRFF-r were used, and 6 of 23
TMP/SMX-sensitive S. maltophilia isolates also yielded
the correct-sized amplification products.
To determine whether the locations of the ISCR
sequences in the S. maltophilia isolates are chromosomal
or plasmid mediated, plasmid DNA was prepared from
each isolate and used as a template for ISCR-PCR and
Southern hybridization analysis in a similar manner as
described for sul2. In every case, a product of the size
expected of ISCR sequence amplification was obtained.
Hence, in those isolates that possess an ISCR element, the
element is located on a plasmid (data not shown). The PCR
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Figure 1. Schematic diagram of class 1 integrons from
Stenotrophomonas maltophilia isolates. A) isolates 1893 and
9431; B) isolates 489, 9189, and 12221; C) isolates 3438 and
3444. Arrows depict direction of transcription, and shaded boxes
represent gene cassettes found within the integron. The dark cir-
cles represent the 59-bp region immediately 5′ to the incorporated
gene cassette.ISCR amplification products were recovered, purified, and
ligated into the cloning vector, PCR-Topo-2.1 (Invitrogen)
and recombinant plasmids were recovered by transforma-
tion of Escherichia coli DH5α. One clone from each trans-
formation was chosen for further study.
Sequence analysis showed that 5/7 amplicons
obtained from TMP/SMX-resistant S. maltophilia isolates
were identical to the equivalent sequence of ISCR2; the
other 2 amplicons were identical to that of ISCR3 (Online
Appendix Table). ISCR2 sequences were identified in iso-
lates originating from North and South America, as well as
from Europe. In contrast, the ISCR3 sequence was identi-
fied only in isolates that originated from Spain.
The ISCR-like elements carried by the sensitive iso-
lates, while clearly related to ISCR1–5, differed markedly
from known ISCR sequences (15). Two variants were
found, which we have designated ISCR9 and ISCR10. The
putative amino acid sequences of ISCR9 and ISCR10 are
≈95% identical to each other and display 30%, 48%, and
74% identity to ISCR2, ISCR,3 and ISCR5, respectively
(Online Appendix Figure, available from http://www.cdc.
gov/EID/13/4/content/559-appG.htm). These novel ISCRs
are harbored in isolates from several different regions,
including South American countries, the United States, and
Turkey (Table).
Identification of Resistance Genes and Sequences
Adjacent to ISCR Elements 
ISCR2 is often associated with various antimicrobial
resistance genes, not least, genes mediating TMP/SMX
resistance (Figure 2) (15). These and other genes normally
associated with ISCR2 were therefore analyzed; these
included dhfrA10, dhfrA9, dhfrA20, floR, tetR, strA, sul2,
and  glmM encoding a truncated phosphoglucosamine
mutase. Pairs of oligonucleotides were used (Table) to
genetically characterize all those S. maltophilia isolates
that possessed an ISCR element.
The floR gene was detected in isolates 2139 and 2170
(which also contains ISCR2) from Turkey and the United
States, respectively, and in isolates 12044 and 12049
(which also contains ISCR3) from Spain. A truncated
glmM allele (∆glmM) was detected in all ISCR2-contain-
ing isolates, and sul2 was found in all ISCR2- and ISCR3-
containing isolates. The dhfr, tetR, and strA genes were not
detected.
Linkage of the ISCR element to ∆glmM, sul2, or floR
was then investigated by PCR analysis, i.e., the oligonu-
cleotide pair CRFF/sul2F is expected to generate a product
if the ISCR sequence is close to sul2 and downstream of it
(Figure 2). Using this strategy, we found that ISCR2 was
linked to ∆glmM and  sul2 in all isolates that possess
ISCR2. The floR gene was also found to be linked to
ISCR2, on the opposite side from ∆glmM and  sul2, in
isolates 2139 and 2170 (Figure 2). Linkage of ISCR3 to
either sul2 or floR was not demonstrated.
Discussion
We report sul2 genes being present in S. maltophilia
and contributing to TMP/SMX resistance. In most cases,
sul2 was carried on large plasmids (≈120 kb), but as
judged by Southern hybridization data, a few appear to be
chromosomally encoded. This study also supports the find-
ings of Barbolla et al. that sul1 present in S. maltophilia is
associated with class 1 integrons (10). Herein, we have
characterized  S. maltophilia sul1 genes from North
America, South America, Spain, Turkey, Italy, and
Germany, and observed that all of them were associated
with class 1 integrons.
Most studies of the location and dissemination of sul2
genes have concentrated on Enterobacteriaceae, such as E.
Stenotrophomonas maltophilia
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Figure 2. Genetic context of various insertion element common
region (ISCR2) elements. Schematic of various GenBank
sequences that harbor the ISCR2 element. Open reading frames
(ORFs) are depicted as open boxes with the direction of transcrip-
tion of the various ORF indicated with arrows. The ORF of the
ISCR2 transposase is highlighted, and the limits of the ISCR2 ele-
ment are shown with vertical lines. The ISCR2 element consists of
an ORF of 1491 bp together with ≈120 bp of upstream sequence
and ≈240 bp of downstream sequence. The ISCR2 element iden-
tified in this study associated with the floR resistance gene is
amplified to show primer sites and positions of the putative oriIS
and terIS of the ISCR2 element. The bold arrow indicates the
direction of rolling circle replication of the ISCR2 element.
GenBank accession numbers of the various sequences are indi-
cated.  S.  enterica,  Salmonella enterica;  S. maltophilia,
Stenotrophomonas maltophila. *This study.coli and Salmonella enterica. Arecent study by Antunes et
al. found sul1, sul2, or sul3 genes in most Portuguese iso-
lates (18); 24 of 200 isolates contained both sul1 and sul2.
sul2 has also recently been identified in S. enterica from
Brazil (20). Similar results have been reported from E. coli
urinary tract isolates in which  ≈26% of strains possessed
both sul1 and sul2 genes (21). A biased study examining
TMP/SMX-resistant E. coli recently reported that 15 of 20
isolates possessed sul2 and that 6 of those also carried sul1
on a class 1 integron (14). Additional studies of E. coli
have shown the intercontinental predominance of sul1
through class 1 integrons (22). Astudy by Pei et al. demon-
strated the correlation of anthropogenic activity with the
presence of sul genes in environmental samples (23).
However, none of the studies demonstrated the genetic ori-
gin of the sul2.
In addition to sul genes associated with plasmids and
class 1 integrons, we investigated whether the S. mal-
tophilia isolates possessed ISCR elements and whether
these could be linked to dhfr or sul genes, as has been
shown (18). Of the 25 TMP/SMX-resistant isolates, 6 har-
bored sul2 linked to ISCR2. However, we could not detect
any sul3 genes. In the isolates with ISCR2, the element
was directly linked to a deleted version of a phosphoglu-
cosamine mutase gene, ∆glmM, as has been reported on
other occasions (Figure 2). This arrangement is identical to
those of 5 other sequences in the EMBL database, in E.
coli isolated from cattle in France and Germany (24), in
the plasmid pRVS1 isolated from a strain of Vibrio
salmonicida from Norway, in a plasmid from a strain of S.
enterica isolated in Japan, and on the chromosome of
Shigella flexneri isolated in the United States (18,24). In
all cases, ∆glmM and sul2 are linked to the end of ISCR2
that accommodates the IS91 oriIS equivalent (Figure 2).
The dual arrangement of ∆glmM and sul2 is also found in
plasmids of marine psychotrophic bacteria isolated in
Norway (GenBank accession no. AJ306553/4), but in
these cases the ISCR2 element appears not to be present.
Two of the isolates harbored a copy of the floR gene
immediately upstream of a copy of ISCR2 (Figure 2), an
arrangement identical to that reported on plasmids found in
isolates of E. coli from cattle in France and Germany (24).
The S. maltophilia isolates investigated in this study came
from Turkey and the United States. Two isolates from
Spain also carry the floR gene but not ISCR2. Instead, the
isolates possess copies of ISCR3, which do not appear to
be linked to floR. The finding of florfenicol-resistant traits
on plasmids in different bacterial species from different
countries highlights the wide geographic spread of this
resistance mechanism. The location of floR next to ISCR2
is such that it is possible, if not probable, that the resistance
gene can be cotransposed with the ISCR element.
The findings within this study are important for sever-
al reasons. First, this is, to our knowledge, the first report
of ISCR elements being found in S. maltophilia isolates. In
6 cases, these were linked to sul2 genes responsible for the
TMP/SMX-resistant phenotype. Moreover, these isolates
were unrelated strains found in different countries. Second,
since TMP/SMX is the mainstay therapy for S. maltophil-
ia infections, the mobilization of sul genes by means of
class 1 integrons and ISCR elements is likely to increase
with TMP/SMX consumption. Third, most sul2 genes in
this study have been found on plasmids, and sul2-contain-
ing plasmids can potentially confer an increase in bacteri-
al “fitness” (25). As yet, such phenomena have only been
explored in Enterobacteriaceae, and it has yet to be estab-
lished whether sul2-carrying plasmids have such an addi-
tive effect in S. maltophilia or for that matter, other
nonfermenting gram-negative bacilli.
These data suggest that microbiology laboratories
need to carefully monitor S. maltophilia TMP/SMX resist-
ance, which has the potential to increase by means of
mobile elements. We also advocate the continued interna-
tional surveillance of antimicrobial drug resistance that
may act as early warning systems for this kind of resist-
ance. Furthermore, yearly monitoring with molecular
probes is advisable.
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